Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes

• Main Authors: Savchenko Liudmyla G. (Author), Digtiar Nataliia I. (Author), Selikhova Liudmyla G. (Author), Kaidasheva Elvira I. (Author), Shlykova Oksana A. (Author), Vesnina Liudmyla E. (Author), Kaidashev Igor P. (Author)
• Format: Book
• Published: Sciendo, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction. Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers.